New multiple myeloma-like score assesses disease severity and risk of progression to active cancer
DNA
Dana-Farber Cancer Institute May 21 2025 A new risk assessment score developed by researchers at Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard reveals how multiple myeloma, a form of blood cancer, begins and progresses from precancerous to malignant states by tracing DNA mutations. The score, called an MM-like score, assesses the severity of disease and risk of progression to active cancer, with higher scores indicating faster progression. In the future, the MM-like
din zilele anterioare